EO2401 PEPTIDE IMMUNOTHERAPY plus NIVOLUMAB plus /- BEVACIZUMAB IN FIRST RECURRENT GLIOBLASTOMA: THE PHASE 1/2 EOGBM1-18/ROSALIE STUDY (NCT04116658)
David Reardon,Ahmed Idbaih,Maria Vieito,Francois Ghiringhelli,Agostina Stradella,Ghazaleh Tabatabai,Michael C. Burger,Iris Mildenberger,Ulrich Herrlinger,Patrick Wen,Mehdi Touat,Antje Wick,Macarena Gonzalez,Alice Hervieu,Marta GilMartin,Mirjam Renovanz,Cecile Gouttefangeas,Ana Maia, Christophe Bonny, Jean-Michel Paillarse, Laurent Chene, Jan Fagerberg,Wolfgang Wick NEURO-ONCOLOGY（2023）
AI 理解论文
溯源树
样例
